Daily Bulletin

Men's Weekly

.

MedAlliance announces Completion of Enrolment in PRISTINE Clinical Trial with SELUTION SLR™ Sirolimus Drug Eluting Balloon

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
MedAlliance announces Completion of Enrolment in PRISTINE Clinical Trial with SELUTION SLR™ Sirolimus Drug Eluting Balloon

NYON, Switzerland, Aug. 13, 2021 /PRNewswire/ -- MedAlliance has announced completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of patients with Below-the-Knee (BTK) disease. SELUTION SLR is the first DEB to be awarded "Breakthrough Device Designation" by the FDA.

MedAlliance announces Completion of Enrolment in PRISTINE Clinical Trial with SELUTION SLR™ Sirolimus Drug Eluting BalloonM...

Read more: MedAlliance announces Completion of Enrolment in PRISTINE Clinical Trial with SELUTION SLR™...

Business News

Why Choosing the Right Labour Hire Company on the Gold Coast Matters for Your Business

Introduction For many businesses across the Gold Coast, staffing remains one of the most significant challenges. The region’s diverse economy, with its mix of tourism, construction, hospitality, and ...

Daily Bulletin - avatar Daily Bulletin

The Importance of Scrap Metal Melbourne Recycling and Car Battery Disposal

In a growing city like Melbourne, sustainability and efficient waste management are continually growing concerns. Of the numerous categories of waste, scrap metal and used vehicle batteries stand out ...

Daily Bulletin - avatar Daily Bulletin

Workplace Health Checks: A Smart Investment for Small Business Success

Running a small business means every team member counts and when poor health leads to absenteeism or low energy, productivity and profits take a hit. Lost workdays, rising healthcare costs, and staff ...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals